Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
CN¥24.35 - CN¥42.00
Next Earnings Date
May 20 2025
Next Earnings Date
May 20 2025
Last Price
Market Cap | CN¥13.30B |
EV | CN¥12.19B |
Shares Outstanding | 459.28M |
Beta | 0.91 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | CN¥29.11 |
P/E 2025E | 22.57x |
P/Revenue 2025E | 1.63x |
Revenue | -15.60% |
EPS | - |
Operating Cash Flow | -24.30% |
Free Cash Flow | -2.90% |
Revenue | 12.90% |
EPS | - |
Operating Cash Flow | -2.50% |
Free Cash Flow | - |
Gross Margin 2025E | 34.92% |
Net Profit Margin 2025E | 2.24% |
ROE 2025E | 0.80% |
ROCE 2024 | -4.86% |
DPS 2025E | CN¥0.17 |
Payout Ratio 2025E | 13.28% |
Div. Yield 2025E | 0.59% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Guangzhou Kingmed Diagnostics Group Co., Ltd.
603882
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Liang, Yaoming
Employees
11,586
Website
www.kingmed.com.cnIPO Date
2017-09-08
Headquarters
No. 10, Spiral 3rd Road, International Biological Island, Guangzhou, Guangdong Province, 510000, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved